Optimising the use of routine immunisation clinics for early childhood development in sub-Saharan Africa

Bolajoko O Olusanya1

  • 1Maternal and Child Health Unit, Department of Community Health and Primary Care, College of Medicine, University of Lagos, Nigeria. b.olusanya@ich.ucl.ac.uk

Vaccine
|May 26, 2009
PubMed

Insights

Integrating developmental disability screening into routine immunisation programs like BCG and DPT can improve child survival and lifelong development in developing regions.

Area of Science:

  • Global Health
  • Developmental Pediatrics
  • Public Health Interventions

Background:

  • High infant and child mortality in developing regions are linked to lifelong developmental impairments in survivors.
  • Routine immunisation programs are established platforms for delivering child health interventions.

Purpose of the Study:

  • To evaluate the integration of developmental disability detection and management into routine immunisation programs.
  • To shift focus from child survival alone to include early childhood development.

Main Methods:

  • Pilot programs in sub-Saharan Africa demonstrated the feasibility of integrating interventions into BCG and DPT immunisations.
  • Utilized existing immunisation infrastructure for early detection and management of developmental disabilities.

Main Results:

  • Successful integration of developmental interventions into immunisation schedules was shown in pilot studies.
  • Demonstrated a viable model for extending child survival programs to address developmental needs.

Conclusions:

  • Routine immunisation programs offer effective platforms for integrated interventions beyond child survival.
  • Such integrated programs align with global strategies like GIVS and UN/World Bank early childhood development policies.
  • Widespread encouragement and support from developmental partners are recommended for these integrated programs in sub-Saharan Africa.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...